Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism

Molecular Metabolism

Volumn 2, Issue 3, 2013, Pages 281-291

  Luche, Elodie ^a,b   Cousin, Béatrice ^a,c,d   Garidou, Lucile ^a,b   Serino, Matteo ^a,b   Waget, Aurélie ^a,b   Barreau, Corinne ^a,c,d   André, Mireille ^c,d   Valet, Philippe ^a,b   Courtney, Michael ^e   Casteilla, Louis ^a,c,d   Burcelin, Rémy ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Institut National de la Sant é et de la Recherche Medicale   (France)

^d CNRS   (France)

^e VAIOMER SAS   (France)

Author keywords

Adipose tissue; Gut microbiota; Inflammation; LPS; Metabolic endotoxemia

Indexed keywords

CD14 ANTIGEN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; ENDOTOXEMIA; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MALE; METABOLIC DISORDER; METABOLIC ENDOTOXEMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEM CELL;

MUS;

EID: 84883259378     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.06.005     Document Type: Article

References (56)

1. Backhed F. Programming of host metabolism by the gut microbiota. Annals of Nutrition and Metabolism 2011, 58(Suppl 2):44-52.
2. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
3. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
4. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
5. Burcelin R., Serino M., Chabo C., Blasco-Baque V., Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetologica 2011, 48:257-273.
6. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
7. Parks B.W., Nam E., Org E., Kostem E., Norheim F., Hui S.T., Pan C., Civelek M., Rau C.D., Bennett B.J., et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metabolism 2013, 17:141-152.
8. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:979-984.
9. Laugerette F., Vors C., Geloen A., Chauvin M.A., Soulage C., Lambert-Porcheron S., Peretti N., Alligier M., Burcelin R., Laville M., et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. Journal of Nutritional Biochemistry 2011, 22:53-59.
10. Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., Chamontin B., Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 2008, 87:1219-1223.
11. Pussinen P.J., Havulinna A.S., Lehto M., Sundvall J., Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011, 34:392-397.
12. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
13. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
14. Wellhoener P., Vietheer A., Sayk F., Schaaf B., Lehnert H., Dodt C. Metabolic alterations in adipose tissue during the early phase of experimental endotoxemia in humans. Hormone and Metabolic Research 2011, 43:754-759.
15. Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology 2004, 25:4-7.
16. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007, 117:175-184.
17. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. Journal of Biological Chemistry 2007, 282:35279-35292.
18. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Medicine 2009, 15:914-920.
19. Bouloumie A., Curat C.A., Sengenes C., Lolmede K., Miranville A., Busse R. Role of macrophage tissue infiltration in metabolic diseases. Current Opinion in Clinical Nutrition and Metabolic Care 2005, 8:347-354.
20. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006, 116:1494-1505.
21. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., Ferrante A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006, 116:115-124.
22. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., Kotani H., Yamaoka S., Miyake K., Aoe S., et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arteriosclerosis, Thrombosis, and Vascular BiologyArteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:84-91.
23. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23.
24. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nature Medicine 2009, 15:921-929.
25. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nature Medicine 2011, 17:610-617.
26. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 2009, 15:930-939.
27. Kim K.A., Gu W., Lee I.A., Joh E.H., Kim D.H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7:e47713.
28. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
29. Song M.J., Kim K.H., Yoon J.M., Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochemical and Biophysical Research Communications 2006, 346:739-745.
30. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L., Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. Journal of Biological Chemistry 2003, 278:9850-9855.
31. Charriere G.M., Cousin B., Arnaud E., Saillan-Barreau C., Andre M., Massoudi A., Dani C., Penicaud L., Casteilla L. Macrophage characteristics of stem cells revealed by transcriptome profiling. Experimental Cell Research 2006, 312:3205-3214.
32. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Penicaud L., Drucker D.J., Magnan C., Burcelin R. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57:2577-2587.
33. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
34. Bjorntorp P., Karlsson M., Pertoft H., Pettersson P., Sjostrom L., Smith U. Isolation and characterization of cells from rat adipose tissue developing into adipocytes. Journal of Lipid Research 1978, 19:316-324.
35. Turnbaugh P., Ridaura V., Faith J., Rey F., Knight R., Gordon J. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 2009, 1:6-14.
36. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
37. Caesar R., Reigstad C.S., Backhed H.K., Reinhardt C., Ketonen M., Ostergren Lunden G., Cani P.D., Backhed F. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 2012.
38. Serino M., Luche E., Gres S., Baylac A., Berge M., Cenac C., Waget A., Klopp P., Iacovoni J., Klopp C., et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012, 61:543-553.
39. Bouloumie A., Casteilla L., Lafontan M. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:1211-1213.
40. Poglio S., De Toni F., Lewandowski D., Minot A., Arnaud E., Barroca V., Laharrague P., Casteilla L., Cousin B. In situ production of innate immune cells in murine white adipose tissue. Blood 2012, 120:4952-4962.
41. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., Smirnova N., Berge M., Sulpice T., Lahtinen S., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 2011, 3:559-572.
42. Schertzer J.D., Tamrakar A.K., Magalhaes J.G., Pereira S., Bilan P.J., Fullerton M.D., Liu Z., Steinberg G.R., Giacca A., Philpott D.J., et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 2011, 60:2206-2215.
43. Fernandez-Real J.M., Perez del Pulgar S., Luche E., Moreno-Navarrete J.M., Waget A., Serino M., Sorianello E., Sanchez-Pla A., Pontaque F.C., Vendrell J., et al. CD14 modulates inflammation-driven insulin resistance. Diabetes 2011, 60:2179-2186.
44. Zaragosi L.E., Wdziekonski B., Villageois P., Keophiphath M., Maumus M., Tchkonia T., Bourlier V., Mohsen-Kanson T., Ladoux A., Elabd C., et al. Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes 2010, 59:2513-2521.
45. Wang L., Li L., Ran X., Long M., Zhang M., Tao Y., Luo X., Wang Y., Jiao Y., Mao X., et al. Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-kappaB pathway and downregulation of AMPK expression. Cardiovascular Toxicology 2013.
46. Bassols J., Ortega F.J., Moreno-Navarrete J.M., Peral B., Ricart W., Fernandez-Real J.M. Study of the proinflammatory role of human differentiated omental adipocytes. Journal of Cellular Biochemistry 2009, 107:1107-1117.
47. Mracek T., Cannon B., Houstek J. IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes. Cytokine 2004, 26:9-15.
48. Menghini R., Fiorentino L., Casagrande V., Lauro R., Federici M. The role of ADAM17 in metabolic inflammation. Atherosclerosis 2013, 228:12-17.
49. Menghini R., Casagrande V., Menini S., Marino A., Marzano V., Hribal M.L., Gentileschi P., Lauro D., Schillaci O., Pugliese G., et al. TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. Diabetes 2012, 61:454-462.
50. Menghini R., Menini S., Amoruso R., Fiorentino L., Casagrande V., Marzano V., Tornei F., Bertucci P., Iacobini C., Serino M., et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 2009, 136(663-672):e664.
51. Moreira A.P., Texeira T.F., Ferreira A.B., Peluzio Mdo C., Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. British Journal of Nutrition 2012, 108:801-809.
52. Pendyala S., Walker J.M., Holt P.R. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012, 142(1100-1101):e1102.
53. Vreugdenhil A.C., Rousseau C.H., Hartung T., Greve J.W., van't Veer C., Buurman W.A. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. Journal of Immunology 2003, 170:1399-1405.
54. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 2009, 50:90-97.
55. Laugerette F., Vors C., Geloen A., Chauvin M.A., Soulage C., Lambert-Porcheron S., Peretti N., Alligier M., Burcelin R., Laville M., et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. Journal of Nutritional Biochemistry 2010.
56. Wang Y., Ghoshal S., Ward M., de Villiers W., Woodward J., Eckhardt E. Chylomicrons promote intestinal absorption and systemic dissemination of dietary antigen (ovalbumin) in mice. PLoS One 2009, 4:e8442.